B+
Bull case
20%
Probability
Target price
$2.01
Analysis reference price unavailable
Analysis 2026-08-28 · RankAlpha Sentiment Codex
PLRX
Pliant TherapeuticsBNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
Current thesis
FORTIFY enrollment momentum, encouraging biomarker observations, and the potential 2027 interim readout provide meaningful oncology optionality. The Q2 cash balance provides near-term financial flexibility.
Posture
Constructive
Lead driver
Sentiment
What changed
Sentiment remains the lead driver in the composite.
What can break
Biotech cash burn may ultimately require additional financing or dilution despite the current cash balance.
Momentum
96
Value
58
Sentiment
64
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $1.15 · Bull $2.01 · Bear $0.55Analysis 2026-08-28; returns require an exact persisted reference.
Data freshness
Prices
Unavailable: Price unavailable
Fundamentals
As of 2026-08-17 • Vendor: Data Vendor v1
Scores
As of 2026-09-11 • Model: HYBRID_IC_RP
AI Memo
As of 2026-08-28 • Model: RankAlpha Sentiment Codex
Investment thesisAs of 2026-09-11
Investment thesis
As of 2026-09-11
Grade is the composite factor band; factor scores use a 0–100 scale. Confidence describes evidence quality, not a probability of return. Score date: 2026-09-11. Definitions
Supporting evidence
What
Grade B · Constructive
Confidence Medium · Net Neutral
Target $1.52
Why
Momentum96 · Δ7d -
Value58 · Δ7d 0.0
Sentiment64 · Δ7d -
So what
Strength-led posture (Net Neutral). Favor watchlist adds and disciplined entries.
Confirming evidence
- • Sentiment remains the lead driver in the composite.
Contradictions & invalidation
- • Biotech cash burn may ultimately require additional financing or dilution despite the current cash balance.
- • FORTIFY is an early-stage study, with interim data not expected until 2027 and no validated efficacy conclusion yet.
- • PLN-101095 remains early-stage with unproven clinical efficacy and durability.
Catalyst clock
2026-12-31
Cash balance provides financing flexibility
Lead driver: Sentiment · See AI snapshot
Momentum
96
9% active weight
Current posture
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Value
58
28% active weight
Current posture
7d trendFlat
Δ7d
0.0
Δ21d
-0.0
Sentiment
64
62% active weight
Current posture
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Why this grade
Composite grade B. Momentum 95.7 / Value 57.9 / Sentiment 63.8
Scenario snapshot
Scenario probability is memo-authored likelihood, not forecast certainty. Targets belong to the analysis dated 2026-08-28. Scenario method
Most likely
B
Base case
55%
Probability
Target price
$1.15
Analysis reference price unavailable
Analysis 2026-08-28 · RankAlpha Sentiment Codex
B-
Bear case
25%
Probability
Target price
$0.55
Analysis reference price unavailable
Analysis 2026-08-28 · RankAlpha Sentiment Codex
Fundamentals (TTM)As of 2026-08-17
Fundamentals (TTM)
As of 2026-08-17
Market Cap
$68.11M
Beta
1.39
Shares Out
61.92M
P/E (TTM) · Derived
-0.5
P/S (TTM)
-
P/FCF (TTM) · Derived
-0.96
Rev YoY
-100.0%
EPS YoY
-48.8%
Gross Margin
-1160.5%
Op Margin
-
Net Debt
-$161.84M
Current Ratio
9.90
As of 2026-09-11 • Updated nightlySource: Internal modelMethods & Data